◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

SCHOTT Pharma AG & Co. KGaA (1SXP) Financial History

Name: SCHOTT Pharma AG & Co. KGaA (1SXP) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Instruments & Supplies · DATA UPDATED 2026-10-06

SCHOTT Pharma AG & Co. KGaA (1SXP) operates in the Medical Instruments & Supplies industry and is headquartered in Mainz, Germany with about 5,002 employees. Its market capitalization is roughly €4 billion. In the fiscal year ended 2025-09-30, 1SXP reported €986M in revenue and €146M in net income.

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.

Interactive charts & full statements → Open the 1SXP valuation workbench →

1SXP Revenue & Earnings History — Annual Income Statement

Income statement	2025-09-30	2024-09-30	2023-09-30	2022-09-30
Total Revenue	€986M	€957M	€899M	€821M
Gross Profit	€332M	€323M	€316M	€296M
Operating Income (EBIT)	€187M	€190M	€171M	€169M
Net Income	€146M	€150M	€152M	€125M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1SXP Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	€282M	€248M	€240M	€248M	€256M	—
Gross Profit	€86M	€75M	€80M	€76M	€96M	—
Operating Income (EBIT)	€49M	€40M	€39M	€41M	€60M	—
Net Income	€39M	€31M	€33M	€34M	€45M	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1SXP Free Cash Flow History

1SXP Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Dividends Paid	€0M	—	—	€0M	€0M	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1SXP Balance Sheet History

Balance sheet	2025-09-30	2024-09-30	2023-09-30	2022-09-30
Total Assets	€1.6B	€1.4B	€1.2B	€1.2B
Total Liabilities	€705M	€649M	€540M	€488M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1SXP viewer.

Other Companies in Medical Instruments & Supplies

3446 · JTEC Corporation — JPY 9 billion
9340 · ASO International, Inc. — JPY 8 billion
7980 · Shigematsu Works Co., Ltd. — JPY 6 billion
YPSN · Ypsomed Holding AG — CHF 5 billion
QMSMEDI · QMS Medical Allied Services Limited — ₹4 billion
7782 · Sincere Co., LTD. — JPY 3 billion
TOG · Thai Optical Group Public Company Limited — THB 3 billion
OBCK · Ottobock SE & Co. KGaA — €3 billion

← 1SN All “0-9” companies 1U1 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.